Aia Group LTD Insulet Corp Transaction History

Aia Group LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	BUY	$272.48 - $330.23 $387,194 - $469,256	1,421 Added 25.16%	7,069 $2.04 Million
Q1 2023 Apr 28, 2023	BUY	$276.36 - $326.03 $792,324 - $934,728	2,867 Added 103.09%	5,648 $1.8 Million
Q4 2022 Jan 31, 2023	SELL	$212.22 - $313.46 $122,875 - $181,493	-579 Reduced 17.23%	2,781 $818,000
Q3 2022 Nov 04, 2022	BUY	$224.6 - $281.45 $150,032 - $188,008	668 Added 24.81%	3,360 $771,000
Q2 2022 Aug 11, 2022	SELL	$186.4 - $279.02 $183,790 - $275,113	-986 Reduced 26.81%	2,692 $587,000
Q1 2022 May 06, 2022	BUY	$194.8 - $275.7 $469,662 - $664,712	2,411 Added 190.29%	3,678 $980,000
Q4 2021 Feb 11, 2022	BUY	$255.32 - $318.29 $323,490 - $403,273	1,267 New	1,267 $337,000

659

63.5M

385K

773K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $16.2B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Aia Group LTD, based on Form 13F filings with the SEC.

Stay updated on Aia Group LTD with notifications on news.